SEARCH

SEARCH BY CITATION

References

  • 1
    Minematsu K, Yamaguchi T, Omae T. ‘Spectacular shrinking deficit’. Neurology 1992; 42: 15762.
  • 2
    Kimura K, Minematsu K, Yamaguchi T. Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2005; 76: 67983.
  • 3
    Nedeltchev K, Schwegler B, Haefeli T, Brekenfeld C, Gralla J, Fischer U, Arnold M, Remonda L, Schroth G, Mattle HP. Outcome of stroke with mild or rapidly improving symptoms. Stroke 2007; 38: 25315.
  • 4
    Baumann CR, Baumgartner RW, Gandjour J, von Büdingen HC, Siegel AM, Georgiadis D. Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms. Stroke 2006; 37: 13323.
  • 5
    Sadanaga T, Sadanaga M, Ogawa S. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy. J Am Coll Cardiol 2010; 55: 222531.
  • 6
    Lip G, Lowe G. Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci 1995; 89: 20514.
  • 7
    Habara S, Dote K, Kato M, Sasaki S, Goto K, Takemoto H, Hasegawa D, Matsuda O. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 2007; 28: 221722.
  • 8
    Lip G, Lowe G, Rumley A, Dunn FG. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J 1995; 73: 52733.